CorporateAstraZeneca Gets Central Drugs Standard Control Organisation Approval For Durvalumab In Gastric Cancer TreatmentBY PTI
NewsZydus Lifesciences Signs Deal with Myriad Genetics for Cancer-Risk Assessment Diagnostic TestsBY PTI